Mimoza Basholli-Salihu

Dr. Mimoza Basholli-Salihu

Department of Pharmaceutical Technology and Drug Analysis, Faculty of Medicine, University of Prishtina, 10 000 Prishtina, Kosovo

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ASAida Loshaj Shala
Aida Loshaj Shala
Ilaria ArduinoIlaria Arduino
Ilaria Arduino
MBMimoza Basholli-Salihu
Mimoza Basholli-Salihu
Nunzio DenoraNunzio Denora
Nunzio Denora
The development of efficient treatments for tumors affecting the central nervous system (CNS) remains an open challenge. Particularly, gliomas are the most malignant and lethal form of brain tumors in adults, causing death in patients just over 6 months after diagnosis without treatment. The current treatment protocol consists of surgery, followed using synthetic drugs and radiation. However, the efficacy of these protocols is associated with side effects, poor prognosis and with a median survival of fewer than two years. Recently, many studies were focused on applying plant-derived products to manage various diseases, including brain cancers. Quercetin is a bioactive compound derived from various fruits and vegetables (asparagus, apples, berries, cherries, onions and red leaf lettuce). Numerous in vivo and in vitro studies highlighted that quercetin through multitargeted molecular mechanisms (apoptosis, necrosis, anti-proliferative activity and suppression of tumor invasion and migration) effectively reduces the progression of tumor cells. This review aims to summarize current developments and recent advances of quercetin’s anticancer potential in brain tumors. Since all reported studies demonstrating the anti-cancer potential of quercetin were conducted using adult models, it is suggested to expand further research in the field of paediatrics. This could offer new perspectives on brain cancer treatment for paediatric patients.

1 June 2022
Verified
Journal Article
Closed access
TKT. L. Kryeziu
T. L. Kryeziu
EHE. Haloci
E. Haloci
ALA. Loshaj-Shala
A. Loshaj-Shala
UBU. Bagci
U. Bagci
AOA. Oral
A. Oral
MBMimoza Basholli-Salihu
Mimoza Basholli-Salihu

30 April 2024 in Physiological Research
Verified
Journal Article
Closed access
SRS Reçica
S Reçica
IKI Kryeziu
I Kryeziu
QTQ Thaçi
Q Thaçi
DAD Avtanski
D Avtanski
MMM Mladenov
M Mladenov
RSRb Sopi
Rb Sopi
Oxygen therapy provides an important treatment for preterm and low-birth-weight neonates, however, it has been shown that prolonged exposure to high levels of oxygen (hyperoxia) is one of the factors contributing to the development of bronchopulmonary dysplasia (BPD) by inducing lung injury and airway hyperreactivity. There is no effective therapy against the adverse effects of hyperoxia. Therefore, this study was undertaken to test the hypothesis that natural phytoalexin resveratrol will overcome hyperoxia-induced airway hyperreactivity, oxidative stress, and lung inflammation. Newborn rats were exposed to hyperoxia (fraction of inspired oxygen - FiO2>95 % O2) or ambient air (AA) for seven days. Resveratrol was supplemented either in vivo (30 mg·kg-1·day-1) by intraperitoneal administration or in vitro to the tracheal preparations in an organ bath (100 μM). Contractile and relaxant responses were studied in tracheal smooth muscle (TSM) using the in vitro organ bath system. To explain the involvement of nitric oxide in the mechanisms of the protective effect of resveratrol against hyperoxia, a nitric oxide synthase inhibitor – Nω-nitro-L-arginine methyl ester (L-NAME), was administered in some sets of experiments. The superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities and the tumor necrosis factor-alpha (TNF-α) and interleukin-1β (IL-1β) levels in the lungs were determined. Resveratrol significantly reduced contraction and restored the impaired relaxation of hyperoxia-exposed TSM (p<0.001). L-NAME reduced the inhibitory effect of resveratrol on TSM contractility, as well as its promotion relaxant effect (p<0.01). Resveratrol preserved the SOD and GPx activities and decreased the expression of TNF-α and IL-1β in hyperoxic animals. The findings of this study demonstrate the protective effect of resveratrol against hyperoxia-induced airway hyperreactivity and lung damage and suggest that resveratrol might serve as a therapy to prevent the adverse effects of neonatal hyperoxia. Keywords: Bronchopulmonary dysplasia • Hyperoxia • Airway hyperreactivity • Resveratrol • Pro-inflammatory cytokines

1 May 2024
Verified
Journal Article
Closed access
TKT. Kryeziu
T. Kryeziu
UBU. Bagci
U. Bagci
ALA. Loshaj-Shala
A. Loshaj-Shala
AOA. Oral
A. Oral
GSGJ. Stefkov
GJ. Stefkov
MBMimoza Basholli-Salihu
Mimoza Basholli-Salihu

8 April 2025 in Journal of Research in Pharmacy
Verified
Journal Article
Open access
PDF file
ASAida Shala
Aida Shala
EHEntela Haloci
Entela Haloci
TKToskë Kryeziu
Toskë Kryeziu
AHArsim Haliti
Arsim Haliti
MBMimoza Basholli-Salihu
Mimoza Basholli-Salihu
MMMonika Mueller
Monika Mueller
The bioavailability of anthocyanins is crucial for conveying their health benefits, but they are poorly absorbed in the gastrointestinal tract (GIT). The deglycosylation of anthocyanins is the key step in improving their bioavailability and bioactivity. This study investigated the potential of β-glucosidase and β-galactosidase cell-free enzymes from Bifidobacterium infantis, on glycolytic hydrolysis of essential anthocyanins, including Cyanidin-3-O-β-D-glucoside (C3-Glu), Malvidin-3- O-β-D-glucoside (M3-Glu), Cyanidin-3-O-β-D-galactoside (C3-Gal) and Delphinidin-3-O-β-D-glucoside (D3-Glu). According to our previous work, Bifidobacterium infantis (B. infantis) was chosen for this study due to its high β- glucosidase and β-galactosidase activity. The anthocyanin glycosides' stability was also evaluated to distinguish chemical instability from enzymatic degradation. B. infantis β-glucosidase exerted the highest activity toward C3-Glu, forming high levels of protocatechuic acid as an active compound, with lower hydrolytic rates observed for M3-Glu. Additionally, B. infantis's β-galactosidase activity was efficient against C3-Gal. According to this study, B. infantis prefers cyanidin glucoside and cyanidin galactoside as substrates. Under experimental circumstances, delphinidin exhibited lower chemical stability, but malvidin and cyanidin glycosides exhibited similar stability. In conclusion, chemical instability is the cause of delphinidin's rate of degradation. According to these results, B. infantis may be utilized as a probiotic supplement to improve the health advantages and bioavailability of meals high in anthocyanins, supporting the development of functional foods and medicinal formulations.

22 August 2026 in BioNanoScience
Verified
Journal Article
Closed access
PDF file
VLVenesa Lupçi
Venesa Lupçi
UBUfuk Bağci
Ufuk Bağci
ASAida Loshaj Shala
Aida Loshaj Shala
AZAndreas Zimmer
Andreas Zimmer
TKToskë Kryeziu
Toskë Kryeziu
MBMimoza Basholli-Salihu
Mimoza Basholli-Salihu